Q-Gesic
Brand names,
Q-Gesic
Analogs
Q-Gesic
Brand Names Mixture
Q-Gesic
Chemical_Formula
C20H23NS
Q-Gesic
RX_link
No information avaliable
Q-Gesic
fda sheet
Q-Gesic
msds (material safety sheet)
Q-Gesic
Synthesis Reference
No information avaliable
Q-Gesic
Molecular Weight
309.469 g/mol
Q-Gesic
Melting Point
< 25 oC
Q-Gesic
H2O Solubility
Soluble as HCl salt
Q-Gesic
State
Liquid
Q-Gesic
LogP
5.7
Q-Gesic
Dosage Forms
Tablets (oral, 1 mg)
Q-Gesic
Indication
Used for the symptomatic treatment of parkinsonism.
Q-Gesic
Pharmacology
Metixene is a tertiary antimuscarinic with actions similar to those of atropine; it also has antihistaminic and direct antispasmodic properties. It is used for the symptomatic treatment of parkinsonism, including the alleviation of the extrapyramidal syndrome induced by other drugs such as phenothiazines, but, like other antimuscarinics, it is of no value against tardive dyskinesias. Metixene has been discontinued.
Q-Gesic
Absorption
Absorbed in the gastrointestinal tract following oral administration, however the extent of absorption is not known.
Q-Gesic
side effects and Toxicity
Signs of overdose include dilated and sluggish pupils, warm, dry skin, facial flushing, decreased secretions of the mouth, pharynx, nose, and bronchi, foul-smelling breath, elevated temperature, tachycardia, cardiac arrhythmias, decreased bowel sounds, urinary retention, delirium, disorientation, anxiety, hallucinations, illusions, confusion, incoherence, agitation, hyperactivity, ataxia, loss of memory, paranoia, combativeness, and seizures.
Q-Gesic
Patient Information
Q-Gesic
Organisms Affected
Humans and other mammals